Hilde Janssen

Hilde Janssen

UNVERIFIED PROFILE

Are you Hilde Janssen?   Register this Author

Register author
Hilde Janssen

Hilde Janssen

Publications by authors named "Hilde Janssen"

Are you Hilde Janssen?   Register this Author

22Publications

504Reads

24Profile Views

A comparison of a brachytherapy and an external beam radiotherapy boost in breast-conserving therapy for breast cancer: local and any recurrences.

Strahlenther Onkol 2019 Apr 2;195(4):310-317. Epub 2019 Jan 2.

Department of Oncology, Experimental Radiation Oncology, KU Leuven-University of Leuven, 3000, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-018-1413-0DOI Listing
April 2019

Validation of a normal tissue complication probability model for late unfavourable aesthetic outcome after breast-conserving therapy.

Acta Oncol 2019 Apr 14;58(4):448-455. Epub 2019 Jan 14.

a Department of Oncology, Experimental Radiation Oncology , KU Leuven - University of Leuven , Leuven , Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2018.1548775DOI Listing
April 2019

RAD51B in Familial Breast Cancer.

Authors:
Liisa M Pelttari Sofia Khan Mikko Vuorela Johanna I Kiiski Sara Vilske Viivi Nevanlinna Salla Ranta Johanna Schleutker Robert Winqvist Anne Kallioniemi Thilo Dörk Natalia V Bogdanova Jonine Figueroa Paul D P Pharoah Marjanka K Schmidt Alison M Dunning Montserrat García-Closas Manjeet K Bolla Joe Dennis Kyriaki Michailidou Qin Wang John L Hopper Melissa C Southey Efraim H Rosenberg Peter A Fasching Matthias W Beckmann Julian Peto Isabel Dos-Santos-Silva Elinor J Sawyer Ian Tomlinson Barbara Burwinkel Harald Surowy Pascal Guénel Thérèse Truong Stig E Bojesen Børge G Nordestgaard Javier Benitez Anna González-Neira Susan L Neuhausen Hoda Anton-Culver Hermann Brenner Volker Arndt Alfons Meindl Rita K Schmutzler Hiltrud Brauch Thomas Brüning Annika Lindblom Sara Margolin Arto Mannermaa Jaana M Hartikainen Georgia Chenevix-Trench Laurien Van Dyck Hilde Janssen Jenny Chang-Claude Anja Rudolph Paolo Radice Paolo Peterlongo Emily Hallberg Janet E Olson Graham G Giles Roger L Milne Christopher A Haiman Fredrick Schumacher Jacques Simard Martine Dumont Vessela Kristensen Anne-Lise Borresen-Dale Wei Zheng Alicia Beeghly-Fadiel Mervi Grip Irene L Andrulis Gord Glendon Peter Devilee Caroline Seynaeve Maartje J Hooning Margriet Collée Angela Cox Simon S Cross Mitul Shah Robert N Luben Ute Hamann Diana Torres Anna Jakubowska Jan Lubinski Fergus J Couch Drakoulis Yannoukakos Nick Orr Anthony Swerdlow Hatef Darabi Jingmei Li Kamila Czene Per Hall Douglas F Easton Johanna Mattson Carl Blomqvist Kristiina Aittomäki Heli Nevanlinna

PLoS One 2016 5;11(5):e0153788. Epub 2016 May 5.

Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0153788PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858276PMC
July 2017

Boost delineation in breast radiation therapy: Isotropic versus anisotropic margin expansion.

Pract Radiat Oncol 2016 Nov - Dec;6(6):e243-e248. Epub 2016 Mar 19.

University Hospitals Leuven/KU Leuven, Department of Radiation-Oncology, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2016.03.005DOI Listing
March 2017

Validation of the Web-Based IBTR! 2.0 Nomogram to Predict for Ipsilateral Breast Tumor Recurrence After Breast-Conserving Therapy.

Int J Radiat Oncol Biol Phys 2016 08 2;95(5):1477-1484. Epub 2016 Apr 2.

Department of Oncology, KU Leuven - University of Leuven, Leuven, Belgium; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.03.036DOI Listing
August 2016

Evaluation of a breast cancer nomogram to predict ipsilateral breast relapse after breast-conserving therapy.

Radiother Oncol 2016 04 12;119(1):45-51. Epub 2016 Feb 12.

KU Leuven - University of Leuven, Department of Oncology, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium. Electronic address:

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2012/01/09/JCO.2011.36
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S016781401600054
Publisher Site
http://dx.doi.org/10.1016/j.radonc.2016.01.023DOI Listing
April 2016

Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram.

Cancer J 2014 Jan-Feb;20(1):1-7

From the *Radiotherapy Departement, AZ Delta, Roeselare, Belgium; †Radiotherapy Departement, University Hospital Gasthuisberg, Leuven, Belgium; ‡Biostatistics and Statistic Bioinformatica Center Leuven, Leuven, Belgium; §Epidemiology & Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY; and ∥Breast Surgery Service, Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000025DOI Listing
May 2015

Common breast cancer susceptibility loci are associated with triple-negative breast cancer.

Cancer Res 2011 Oct 15;71(19):6240-9. Epub 2011 Aug 15.

Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-1266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327299PMC
October 2011

Fusion of ETV6 to GOT1 in a case with myelodysplastic syndrome and t(10;12)(q24;p13).

Haematologica 2006 Jul 1;91(7):949-51. Epub 2006 Jun 1.

Department of Human Genetics, Flanders Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
July 2006

Interaction partners for human ZNF384/CIZ/NMP4--zyxin as a mediator for p130CAS signaling?

Exp Cell Res 2006 Apr 28;312(7):1194-204. Epub 2006 Feb 28.

Human Genome Laboratory, Department of Human Genetics, University of Leuven, Flanders Interuniversity Institute for Biotechnology (VIB), VIB4, Campus Gasthuisberg O&N 06, Herestraat 49 Box 602, B-3000 Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2006.02.001DOI Listing
April 2006

Resistance of hypoxic cells to ionizing radiation is influenced by homologous recombination status.

Int J Radiat Oncol Biol Phys 2006 Feb 15;64(2):562-72. Epub 2005 Dec 15.

Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.09.031DOI Listing
February 2006

Thymidine analogues to assess microperfusion in human tumors.

Int J Radiat Oncol Biol Phys 2005 Jul;62(4):1169-75

Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.03.063DOI Listing
July 2005

Cellular transformation of NIH3T3 fibroblasts by CIZ/NMP4 fusions.

J Cell Biochem 2005 Apr;94(6):1112-25

Human Genome Laboratory, Department of Human Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), Katholieke Universiteit Leuven, Herestraat 49, B-3000 Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.20369DOI Listing
April 2005

Differentiation-associated staining with anti-pimonidazole antibodies in head and neck tumors.

Radiother Oncol 2004 Jan;70(1):91-7

Division of Experimental Therapy, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2003.09.012DOI Listing
January 2004

Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21.

Eur J Nucl Med Mol Imaging 2002 Sep 23;29(9):1206-11. Epub 2002 Jul 23.

Department of Radiotherapy, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-002-0888-0DOI Listing
September 2002